Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anticoagulant Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103626759A details a high-yield synthesis of Apixaban intermediate using dichloromethane, offering significant cost reduction and purity improvements for API manufacturing supply chains.
Patent CN118146163A reveals high-yield benzimidazole derivatives with superior thrombin inhibition. Discover cost-effective synthesis and supply chain advantages for pharmaceutical intermediates.
Patent CN108273523B reveals a low-pressure hydrogenation method for dabigatran intermediates using a novel Pt-Ni-WS2 catalyst, offering superior selectivity and solid product formation.
Discover a novel diethylene glycol route for synthesizing 4-(4-aminophenyl)morpholine-3-one. This eco-friendly, high-yield process offers significant cost reduction in API manufacturing.
Patent CN116003384A reveals a novel synthetic route for dabigatran intermediates featuring early-stage cyclization and NHPI oxidation for superior yield and purity.
Patent CN103387566B reveals a low-cost synthesis route for Dabigatran intermediates. Achieve high purity and supply chain stability with optimized crystallization processes.
Novel 5-step synthesis of Rivaroxaban intermediate offering high yield, low waste, and scalable production for global API manufacturers.
Novel synthetic route for Rivaroxaban intermediate ensures high purity and cost efficiency for reliable pharmaceutical intermediates supplier partnerships.
Patent CN117384186A reveals high-yield synthesis for edoxaban intermediates. Stable hydrochloride salt form ensures supply continuity and cost efficiency.
Patent CN105085370B reveals a novel route for Rivaroxaban intermediates. Achieve high purity and yield with scalable triphosgene acylation for reliable supply.
Patent CN108997247A discloses efficient oxidation route for Rivaroxaban intermediate enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN111763157B reveals a novel one-step asymmetric synthesis for chiral amino compounds, enabling cost reduction in pharmaceutical manufacturing and safer scale-up.
Eliminate HCl gas handling and corrosion risks with EDC-NHS coupling. Achieve 92% yield and 99.7% purity for scalable betrixaban maleate production.